Building and Testing Performance Measures: Ensuring Quality in Dermatology

The discussion centers on the complexities of developing and testing performance measures in dermatology, crucial for ensuring quality patient care. The American Academy of Dermatology has established a Performance Measures Committee dedicated to identifying gaps in care and developing relevant measures. Current initiatives aim to align these measures with national standards set by organizations like CMS and other healthcare improvement bodies, focusing on key areas like equity and outcomes. The measured process includes rigorous gap analysis, collaboration among expert committees to draft and refine measures, and involvement from patient advocates. The measures encompass various categories, including process, outcome, and cost measures, each contributing to a holistic approach to quality assessment. Once developed, measures undergo peer review and scrutiny from CMS, involving a prolonged approval process often extending over multiple years. The measures aim to reflect improvements in patient care while balancing the administrative burden on clinical practices. Engagement with Qualified Clinical Data Registries (QCDRs) offers a path to specialty-specific measures, although these must demonstrate significance distinct from existing quality payment measures. Ultimately, the initiative serves as a framework for consistent and meaningful improvements in dermatologic care.